Single-Port Robot-Assisted Post-Chemotherapy Unilateral Retroperitoneal Lymph Node Dissection: Feasibility and Surgical Considerations
As far as we know this is the first reported case of SP-rRPLND in Europe. The LAA provides safe access while minimizing morbidity, potentially improving recovery (8). A unilateral approach, avoiding transperitoneal access, may further reduce morbidity (9). Future studies should validate long-term oncological outcomes and compare SP-rRPLND with multiport and open approaches. SP-rRPLND represents a promising advancement in minimally invasive testicular cancer surgery.
Authors
- Roberto Contieri (ORCID: https://orcid.org/0000-0001-7011-0537)
- Rocco Damiano (ORCID: https://orcid.org/0000-0001-6093-3644)
- Roberto Corrado
- Sisto Perdonà (ORCID: https://orcid.org/0000-0001-8683-4644)
- Giovanna Canfora
- Alessandro Izzo (ORCID: https://orcid.org/0000-0003-3145-7313)
- Gianluca Spena (ORCID: https://orcid.org/0000-0002-6714-9315)
- Riccardo Autorino (ORCID: https://orcid.org/0000-0001-7045-7725)
- Savio Domenico Pandolfo (ORCID: https://orcid.org/0000-0001-9621-3059)
- Francesco Passaro
Institutions
- Rush University Medical Center (US)
- Magna Graecia University (IT)
- Federico II University Hospital (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Tumori Foundation (US)
Publication Details
- Journal
- International braz j urol
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1590/s1677-5538.ibju.2025.0091
- Citations
- 4
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.03